The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.
暂无分享,去创建一个
R. Weinshilboum | S. Oparil | J. Cleeman | T. Thom | C. Lenfant | B. Falkner | S. Julius | D. Levine | J. Stamler | D. Levy | L. Agodoa | W. Frishman | Black Hr | Cohen Jd | Kaplan Nm | Ferdinand Kc | Chobanian Av | Dustan Hp | Gifford Rw | M. Moser | Sheps Sg | August Pa | Bakris Gl | V. Burt | W. Busse | Carter Bl | Chesley Fd | Cohn Jn | Cregler Ll | C. Crespo | Cushman Wc | J. Cutler | Darrow | DeQuattro Vl | Devereux Rb | Dworkin Ld | Elliott Wj | M. Epstein | Ferrario Cm | Flack Jm | F. Ed | Green La | Grimm Rh | Hagberg Jm | Hall Wd | J. Handler | S. Havas | Hill Mn | Horan Mj | Hsueh Wa | Hyman Bn | Izzo Jl | K. Jamerson | Kiley Jp | Kochar Ms | Kolasa Km | Krakoff Lr | Lindheimer | Luepker Rv | M. Mel | B. Massie | Materson Bj | J. Merchant | Messerli Fh | Miller Nh | Moore Ma | L. MustoneAlexander | Perry Hm | Pickering Tg | Pratt Jh | Ram Cvs | R. Os | Reed Jw | Roberts Rw | Roccella Ej | Rogus Sd | E. Saunders | E. Schron | G. Schwartz | Sibai Bm | D. Snyder | Sowers | R. Temple | S. Textor | Vidt Dg | M. Weber | Weinberger Mh | Whelton Pk | Whisnant Jp | Wiebers Do | Winston Mc | Wright Jt | L. Casser | Colman Pj | T. Edwards | Feeley Dm | J. Gajewski | W. Manger | M. Ec | Nickey Wa | Secrest Bg | Singer Eh | Wilson Gj | Young Jm | Bachman Jw | Campese Vm | Carr Aa | M. Hand | Holden Dc | Jamieson Mj | Mensah Ga | M. Prisant | Sullivan Jm | Wilson Dj | G. Morosco | A. De | D. Waugh | Sheldon G. Sheps | S. Sheps
[1] D. S. Fleming,et al. Hypertension control. , 1975, Minnesota medicine.
[2] David H. Gustafson,et al. Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes , 1976 .
[3] B. Garrett,et al. Moderate sodium restriction and various diuretics in the treatment of hypertension. , 1981, Archives of internal medicine.
[4] R P Russell,et al. Five-year blood pressure control and mortality following health education for hypertensive patients. , 1983, American journal of public health.
[5] S. Blair,et al. Physical fitness and incidence of hypertension in healthy normotensive men and women. , 1984, JAMA.
[6] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[7] J. Kotchen,et al. Impact of a rural high blood pressure control program on hypertension control and cardiovascular disease mortality. , 1986, JAMA.
[8] T S Warrender,et al. Randomised trial of treatment of hypertension in elderly patients in primary care. , 1986, British medical journal.
[9] N. Shulman,et al. Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program. , 1986, Progress in cardiovascular diseases.
[10] F. Messerli. Osler's maneuver, pseudohypertension, and true hypertension in the elderly. , 1986, American Journal of Medicine.
[11] M. Blaufox,et al. Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. , 1987, Archives of internal medicine.
[12] F. Tristani,et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .
[13] S. Thompson,et al. The relationship between smoking and the response to anti-hypertensive treatment in mild hypertensives in the Medical Research Council's trial of treatment. , 1987, International journal of epidemiology.
[14] M. Pagala,et al. Rhabdomyolysis related to cocaine abuse. , 1988, Annals of internal medicine.
[15] M. Kryger,et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. , 1988, Chest.
[16] W. L. Ooi,et al. Impact of Race on Treatment Response and Cardiovascular Disease Among Hypertensives , 1989, Hypertension.
[17] A. Dyer,et al. Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. , 1989, JAMA.
[18] R. Juster,et al. Prognostic value of ambulatory blood pressure measurements: further analyses. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[19] C. Bulpitt,et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. , 1989, BMJ.
[20] E. McCarthy,et al. Combined α/β‐blockade versus β1‐selective blockade in essential hypertension in black and white patients , 1990 .
[21] L. Goldman,et al. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. , 1990, JAMA.
[22] R. Ward. Familial aggregation and genetic epidemiology of blood pressure , 1990 .
[23] L. Hillis,et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. , 1990, Annals of internal medicine.
[24] E. O’Brien,et al. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. , 1990, Journal of hypertension.
[25] A. J. Dunning,et al. Relaxation therapy and continuous ambulatory blood pressure in mild hypertension: a controlled study. , 1990, BMJ.
[26] D. Hillman,et al. Association of sleep apnoea with myocardial infarction in men , 1990, The Lancet.
[27] C. Lieber,et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. , 1990, The New England journal of medicine.
[28] K. Anderson,et al. An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.
[29] C. Mulrow,et al. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? , 1991, JAMA.
[30] J. Laragh,et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.
[31] J. Stamler. Blood pressure and high blood pressure. Aspects of risk. , 1991, Hypertension.
[32] Edward M. Hitchcock,et al. Alcohol consumption--a risk factor for hemorrhagic and non-hemorrhagic stroke. , 1991, The American journal of medicine.
[33] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[34] T. Sos. Angioplasty for the Treatment of Azotemia and Renovascular Hypertension in Atherosclerotic Renal Artery Disease , 1991, Circulation.
[35] J. Lalouel,et al. A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension , 1992, Nature.
[36] R. Portman,et al. Hypertension during reduction of long-term steroid therapy in young subjects with asthma. , 1992, The Journal of allergy and clinical immunology.
[37] G. Striker. Modification of diet in renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[39] L. Hansson,et al. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Commentary , 1992 .
[40] H. Black,et al. Refractory hypertension. , 1992, The New England journal of medicine.
[41] A S Berson,et al. National Standard for Measurement of Resting and Ambulatory Blood Pressures With Automated Sphygmomanometers , 1993, Hypertension.
[42] L. Kuller,et al. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. , 1993, JAMA.
[43] D. Levy,et al. The natural history of borderline isolated systolic hypertension. , 1993, The New England journal of medicine.
[44] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .
[45] L. Appel,et al. Ambulatory Blood Pressure Monitoring and Blood Pressure Self-Measurement in the Diagnosis and Management of Hypertension , 1993, Annals of Internal Medicine.
[46] C. Lewis,et al. Treatment of Mild Hypertension Study: Final Results , 1993 .
[47] B. Kasiske,et al. Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.
[48] A. Rodgers,et al. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. , 1993, Clinical and experimental hypertension.
[49] D J Reda,et al. Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .
[50] B. Morgenstern,et al. Human blood pressure determination by sphygmomanometry. , 1993, Circulation.
[51] T. Riles,et al. Plasma catecholamine concentrations during abdominal aortic aneurysm surgery: The link to perioperative myocardial ischemia , 1993, Annals of vascular surgery.
[52] D. Levy,et al. A multifactorial approach to coronary disease risk assessment. , 1993, Clinical and experimental hypertension.
[53] R S Paffenbarger,et al. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.
[54] A Tremblay,et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.
[55] K. Koury,et al. A Multifactorial Trial Design to Assess Combination Therapy in Hypertension: Treatment With Bisoprolol and Hydrochlorothiazide , 1994 .
[56] G. Reboldi,et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.
[57] W. L. Ooi,et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. , 1994, Hypertension.
[58] M. Cirillo,et al. Urinary sodium to potassium ratio and urinary stone disease. The Gubbio Population Study Research Group. , 1994, Kidney international.
[59] E. Lander,et al. Genetic dissection of complex traits science , 1994 .
[60] L. Lind,et al. Long-term metabolic effects of antihypertensive drugs. , 1994, American heart journal.
[61] R. Collins,et al. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. , 1994, British medical bulletin.
[62] Jönsson Bg. Cost-benefit of treating hypertension. , 1994 .
[63] S. Sheps,et al. Management of patients with hypertension: a hypertension clinic model. , 1994, Mayo Clinic proceedings.
[64] D. Levy,et al. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. , 1994, Circulation.
[65] R. Klein,et al. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. , 1994, Archives of ophthalmology.
[66] P Whelton,et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.
[67] J. Miller,et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. , 1995, Hypertension.
[68] K. Bønaa,et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. , 1995, Annals of Internal Medicine.
[69] F P Cappuccio,et al. Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. , 1995, American journal of epidemiology.
[70] S. Yusuf,et al. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. , 1995, JAMA.
[71] J. Laragh,et al. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. , 1995, Hypertension.
[72] F. Cappuccio,et al. Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. , 1995, Hypertension.
[73] T. Raghunathan,et al. The risk of myocardial infarction associated with antihypertensive drug therapies. , 1995, JAMA.
[74] R. Glynn,et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. , 1995, Archives of internal medicine.
[75] D. Reda,et al. Response to a Second Single Antihypertensive Agent Used as Monotherapy for Hypertension After Failure of the Initial Drug , 1995 .
[76] B. Kasiske,et al. Effects of Antihypertensive Therapy on Serum Lipids , 1995, Annals of Internal Medicine.
[77] B. Psaty,et al. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. , 1995, Circulation.
[78] L. Ramsay,et al. Treatment of hypertension in the elderly , 1995, Journal of hypertension.
[79] K. Kochanek,et al. Advance report of final mortality statistics, 1991 , 1995 .
[80] D. Kerr,et al. A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. , 1995, The American journal of clinical nutrition.
[81] L. Bang,et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. , 1995, American journal of hypertension.
[82] K. Hansen,et al. Renovascular disease in older patients beginning renal replacement therapy. , 1995, Kidney international.
[83] R. Prineas,et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). , 1995, Circulation.
[84] Daniel L. McGee,et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. , 1995, JAMA.
[85] D. Reda,et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. , 1995, The New England journal of medicine.
[86] P Whelton,et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.
[87] Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study. , 1995, Journal of hypertension.
[88] J. Hollander. The management of cocaine-associated myocardial ischemia. , 1995, The New England journal of medicine.
[89] S. Sheps,et al. American National Standard for nonautomated sphygmomanometers. Summary report. , 1995, American journal of hypertension.
[90] G. Guyatt,et al. Users' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations , 1995 .
[91] A Shamiss,et al. Altered circadian rhythm of blood pressure in shift workers. , 1995, Journal of human hypertension.
[92] G. Bakris,et al. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. , 1996, Archives of internal medicine.
[93] N. Polissar,et al. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. , 1995, American journal of hypertension.
[94] A. Wallace,et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.
[95] P. Elliott,et al. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. , 1996, Annals of internal medicine.
[96] M. Alderman,et al. The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. , 1996, The New England journal of medicine.
[97] M. Lishner,et al. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. , 1996, Archives of internal medicine.
[98] G. Reaven,et al. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.
[99] P. Fioretto,et al. Effects of Cilazapril and Amlodipine on Kidney Function in Hypertensive NIDDM Patients , 1996, Diabetes.
[100] S. Yusuf,et al. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. , 1996, Indian Heart Journal.
[101] R. Vasan,et al. The progression from hypertension to congestive heart failure. , 1996, JAMA.
[102] R. Vasan,et al. The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. , 1996, Archives of internal medicine.
[103] Putting it all together: summary of the NHLBI Workshop on the Epidemiology of Hypertension in Hispanic American, Native American, and Asian/Pacific Islander American Populations. , 1996, Public health reports.
[104] C. Lewis,et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension , 1996 .
[105] S. Goldman. Renal artery angioplasty: technical results and clinical outcome in 320 patients. , 1996, The Journal of urology.
[106] W M O'Fallon,et al. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. , 1996, Stroke.
[107] Dietary protein and blood pressure. , 1996, JAMA.
[108] B. Howard,et al. Hypertension in adult American Indians. The Strong Heart Study. , 1996, Hypertension.
[109] F. Locatelli,et al. Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .
[110] Richard P. Lewis,et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[111] M. Moser,et al. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. , 1996, Journal of the American College of Cardiology.
[112] B. Egan,et al. Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. , 1996, Hypertension.
[113] P. Kowey,et al. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? , 1996, JAMA.
[114] T. Kotchen. Attenuation of hypertension by insulin-sensitizing agents. , 1996, Hypertension.
[115] P. Elliott,et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations , 1996 .
[116] R. Gibbons,et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). , 1996, Journal of the American College of Cardiology.
[117] C. Albert,et al. Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. , 1996, The New England journal of medicine.
[118] D. Phillips,et al. Accuracy of automated finger blood pressure devices. , 1996, Family medicine.
[119] R. Preston,et al. Renal Parenchymal Hypertension: current concepts of pathogenesis and management. , 1996, Archives of internal medicine.
[120] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[121] Alan C. Wilson,et al. Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). , 1996, Circulation.
[122] A. Logan,et al. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.
[123] Jennifer S. Lin,et al. Sociodemographic influences on Hispanic-white differences in blood pressure. , 1996, Public health reports.
[124] Pre-eclampsia-eclampsia 1996: preventable? Have disputes on its treatment been resolved? , 1996, Current opinion in nephrology and hypertension.
[125] M. Weinberger,et al. Salt sensitivity of blood pressure in humans. , 1996, Hypertension.
[126] M. Hill,et al. Enhancing the role of community-health workers in research. , 1996, Image--the journal of nursing scholarship.
[127] W. Boden,et al. Calcium channel antagonists: Fried or Foe in postinfarction patients? , 1996 .
[128] C M O'Connor,et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.
[129] J. Guralnik,et al. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old , 1996, The Lancet.
[130] G. MacGregor,et al. Salt—more adverse effects , 1996, The Lancet.
[131] B. Sibai. Treatment of hypertension in pregnant women. , 1996, The New England journal of medicine.
[132] F. Gueyffier,et al. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. , 1996, Journal of human hypertension.
[133] B. Davis,et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.
[134] S. Leurgans,et al. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. , 1996, Kidney international.
[135] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[136] P. Whelton,et al. Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.
[137] P. Okin,et al. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[138] W. Kannel. Blood pressure as a cardiovascular risk factor: prevention and treatment. , 1996, JAMA.
[139] Choice of initial therapy for hypertension. , 1996, JAMA.
[140] J. Cutler,et al. Randomized trials of sodium reduction: an overview. , 1997, The American journal of clinical nutrition.
[141] Strategies for antihypertensive treatment decisions: how to assess benefits? , 1997, Journal of hypertension.
[142] Y Wang,et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.
[143] L. Hansson,et al. Underestimation of the true benefits of antihypertensive treatment: an assessment of some important sources of error. , 1997, Journal of hypertension.
[144] B. Psaty,et al. Clinical implications of the World Health Organization-International Society of Hypertension statement on calcium antagonists. , 1997, Journal of hypertension.
[145] Xianglin L. Du,et al. Case-control study of stroke and the quality of hypertension control in north west England , 1997, BMJ.
[146] Bertram Pitt,et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.
[147] E. Roccella,et al. Hypertension-related morbidity and mortality in the southeastern United States. , 1997, The American journal of the medical sciences.
[148] R. Devereux,et al. Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? , 1997, Circulation.
[149] P. Whelton,et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings. , 1997, JAMA.
[150] D. Reda,et al. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 1997, Circulation.
[151] Roberto Sega,et al. Blood-pressure control in the hypertensive population , 1997, The Lancet.
[152] A. Stewart,et al. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. , 1997, Archives of internal medicine.
[153] A. Caggiula,et al. Relation of changes in dietary lipids and weight, trial years 1-6, to changes in blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of clinical nutrition.
[154] T. Ohkubo,et al. Proposal of reference values for home blood pressure measurement: prognostic criteria based on a prospective observation of the general population in Ohasama, Japan. , 1997, American journal of hypertension.
[155] J. Ménard,et al. The absolute risk as a guide to influence the treatment decision-making process in mild hypertension. , 1997, Journal of hypertension.
[156] D. Vidt,et al. Cholesterol emboli: a common cause of renal failure. , 1997, Annual review of medicine.
[157] J. Stamler,et al. Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of clinical nutrition.
[158] S. Sheps,et al. Limited echocardiography for hypertensive left ventricular hypertrophy. , 1997, Hypertension.
[159] K. Manton,et al. Chronic disability trends in elderly United States populations: 1982-1994. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[160] A. Caggiula,et al. Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of clinical nutrition.
[161] Cyclosporine, Blood Pressure and Atherosclerosis , 1997 .
[162] J. Robbins,et al. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group. , 1997, The American journal of cardiology.
[163] B. Davis,et al. Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension , 1997 .
[164] Glen D Georger. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population , 1997 .
[165] G. Bakris,et al. Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans. , 1997, Hypertension.
[166] R. Schmieder,et al. Salt. A perpetrator of hypertensive target organ disease? , 1997, Archives of internal medicine.
[167] J. Cutler,et al. Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.
[168] M. Pahor,et al. Use of calcium antagonists and need for perioperative transfusion in older patients with hip fracture: observational study , 1997, BMJ.
[169] M. Hill,et al. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. , 1997, Circulation.
[170] K. Mclaughlin. Effect of renal-artery stenting on progression of renovascular renal failure , 1997, The Lancet.
[171] A. Levey,et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. , 1997, Hypertension.
[172] W. Edwards,et al. Valvular heart disease associated with fenfluramine-phentermine. , 1997, The New England journal of medicine.
[173] M. Alderman,et al. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients , 1997, The Lancet.
[174] C. Hennekens,et al. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. , 1997, JAMA.
[175] S. Textor. Renal failure related to angiotensin-converting enzyme inhibitors. , 1997, Seminars in nephrology.
[176] B. Psaty,et al. Health Outcomes Associated with Antihypertensive Therapies Used as First-Line Agents: A Systematic Review and Meta-analysis , 1998 .
[177] W. Ray,et al. Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas , 1998 .
[178] P. Whelton,et al. Effects of Oral Potassium on Blood Pressure: Meta-Analysis of Randomized Controlled Clinical Trials , 1998 .